Status:
COMPLETED
High Flow Oxygen Therapy and Acute Ischemic Stroke
Lead Sponsor:
Chulalongkorn University
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hypoxemia is common in acute ischemic stroke and associated with neurological deterioration and mortality. However, the benefit of oxygen therapy is controversial. Severity of stroke may affect the be...
Eligibility Criteria
Inclusion
- Age of 18 or more
- Clinical and radiographic findings including computerized tomography of brain compatible with acute ischemic stroke
- Presentation within 72 hours after the stroke onset
- National of Health Stroke Scale (NIHSS) of 5 or more,
- Limb weakness defined as motor power grade of 4 or less,
- Able to give informed consent, or the next of kin was willing to give assent
Exclusion
- Recognized indications for oxygen treatment, such as oxygen saturation on room air of less than 92%, acute left ventricular failure, severe pneumonia, pulmonary emboli, and chronic respiratory failure treated with home oxygen supplementation
- Recognized contraindications for oxygen treatment including chronic hypercapnia and type II respiratory failure
- Subjects with previous diagnosis of obstructive sleep apnea (OSA) or highly suspicious of OSA, screened by STOPBANG score of 5 or more
Key Trial Info
Start Date :
July 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2017
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03402594
Start Date
July 1 2016
End Date
June 30 2017
Last Update
January 18 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.